DeepMed Research

NYU LANGONE HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1841-01-01

Employees: 10K

Market Cap: -

Website: http://www.nyulangone.org

Clinical Trials

Preventive IVIG Therapy for Congenital Heart Block

Early Phase 1

Completed

Conditions: Congenital Heart Block
Autoantibody-associated Heart Block
Neonatal Lupus

Interventions: Drug: intravenous immune globulin (IVIG)

First Posted Date: 2007-04-17

Last Posted Date: 2019-09-30

Lead Sponsor: NYU Langone Health

Target Recruit Count: 20

Registration Number: NCT00460928

Locations: 🇺🇸
Saint Barnabas Medical Center, Livingston, New Jersey, United States
🇺🇸
New York University School of Medicine / NYU-Hospital for Joint Diseases, New York, New York, United States

Cetuximab Plus Biweekly Capecitabine and Oxaliplatin in KRAS Wild Type Metastatic Colorectal Cancer

Phase 2

Completed

Conditions: Colorectal Cancer
Neoplasm Metastasis

Interventions: Drug: Cetuximab
Drug: Oxaliplatin
Drug: Capecitabine

First Posted Date: 2007-03-08

Last Posted Date: 2020-04-03

Lead Sponsor: NYU Langone Health

Target Recruit Count: 36

Registration Number: NCT00444678

Locations: 🇺🇸
New York University Langone Medical Center, New York, New York, United States
🇺🇸
Bellevue Hospital, New York, New York, United States

Thalidomide for Decreasing Collagen Biosynthesis in People With Progressive Systemic Sclerosis

Phase 1

Terminated

Conditions: Scleroderma, Systemic

Interventions: Drug: Placebo thalidomide
Drug: Thalidomide

First Posted Date: 2007-01-04

Last Posted Date: 2016-03-11

Lead Sponsor: NYU Langone Health

Target Recruit Count: 30

Registration Number: NCT00418132

Locations: 🇺🇸
New York University School of Medicine General Clinical Research Center, Bellevue Hospital, New York, New York, United States

Atorvastatin to Prevent Avascular Necrosis of Bone in Steroid Treated Exacerbated Systemic Lupus Erythematosus

Phase 2

Terminated

Conditions: Avascular Necrosis

Interventions: Drug: Atorvastatin
Procedure: MRI, Venipuncture
Drug: Placebo

First Posted Date: 2006-12-19

Last Posted Date: 2018-11-23

Lead Sponsor: NYU Langone Health

Target Recruit Count: 43

Registration Number: NCT00412841

Locations: 🇺🇸
The New York University Hospital For Joint Diseases, New York, New York, United States

NYU/Bellevue WTC Health Impacts Research Registry

Recruiting

Conditions: Exposure to World Trade Center Dust

First Posted Date: 2006-11-29

Last Posted Date: 2024-08-27

Lead Sponsor: NYU Langone Health

Target Recruit Count: 16000

Registration Number: NCT00404898

Locations: 🇺🇸
NYU School of Medicine/Bellevue Hospital, New York, New York, United States

Airways Dysfunction Following WTC Dust Exposure

Completed

Conditions: Pulmonary Diseases

First Posted Date: 2006-11-02

Last Posted Date: 2015-08-20

Lead Sponsor: NYU Langone Health

Target Recruit Count: 500

Registration Number: NCT00395330

Evaluating the Relationship Between Sleep-Disordered Breathing and Daytime Alertness

Completed

Conditions: Sleep Apnea, Obstructive

Interventions: Device: Continuous Positive Airway Pressure (CPAP)

First Posted Date: 2006-10-31

Last Posted Date: 2016-08-05

Lead Sponsor: NYU Langone Health

Target Recruit Count: 144

Registration Number: NCT00393913

Locations: 🇺🇸
NYU Sleep Disorders Center, New York, New York, United States

Cognitive Behavioral Therapy Versus Sertraline in the Treatment of Post-Traumatic Stress Disorder

Phase 4

Terminated

Conditions: Post-Traumatic Stress Disorder

Interventions: Behavioral: Cognitive behavioral therapy (CBT)
Drug: Sertraline

First Posted Date: 2006-10-24

Last Posted Date: 2021-07-21

Lead Sponsor: NYU Langone Health

Target Recruit Count: 39

Registration Number: NCT00391430

Locations: 🇺🇸
NYU Institute for Trauma & Resilience, New York, New York, United States

Organizational Skills Training for Children With Attention Deficit Hyperactivity Disorder

Not Applicable

Completed

Conditions: Attention Deficit Disorder With Hyperactivity

Interventions: Behavioral: Organizational Skills Training
Behavioral: Contingency management (CM)

First Posted Date: 2006-09-27

Last Posted Date: 2013-04-19

Lead Sponsor: NYU Langone Health

Target Recruit Count: 157

Registration Number: NCT00381407

Locations: 🇺🇸
Duke University, Durham, North Carolina, United States
🇺🇸
New York University School of Medicine, New York, New York, United States

Psychiatric and Cognitive Manifestations of Parkinson's Disease

Completed

Conditions: Parkinson's Disease

First Posted Date: 2006-08-04

Last Posted Date: 2019-05-10

Lead Sponsor: NYU Langone Health

Target Recruit Count: 36

Registration Number: NCT00360633

Locations: 🇺🇸
NYU School of Medicine, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy